Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous CIK Cells Plus GC Chemotherapy for Metastatic Nasopharyngeal Carcinoma
NCT01655628Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2012
- Primary completion
- Jul 2014
- Modality
- Prophylactic Vaccines, Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs)
- Countries
- 1
01
Overview
A Phase 2 trial of autologous cytokine-induced killer cells in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
autologous cytokine-induced killer cells
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01655628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01655628.